Orthofix Medical (NASDAQ:OFIX) Now Covered by StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Orthofix Medical (NASDAQ:OFIX – Get Rating) in a research report issued on Friday. The brokerage set a “buy” rating on the medical device company’s stock.

Orthofix Medical Price Performance

Shares of OFIX stock opened at $17.64 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.06 and a quick ratio of 1.89. The company has a market capitalization of $352.98 million, a P/E ratio of -18.00 and a beta of 0.87. The company’s 50-day simple moving average is $20.54 and its two-hundred day simple moving average is $19.24. Orthofix Medical has a one year low of $13.76 and a one year high of $35.34.

Orthofix Medical (NASDAQ:OFIX – Get Rating) last announced its quarterly earnings results on Monday, March 6th. The medical device company reported $0.19 earnings per share for the quarter, topping the consensus estimate of ($0.37) by $0.56. Orthofix Medical had a negative net margin of 4.29% and a positive return on equity of 1.67%. The firm had revenue of $122.23 million during the quarter, compared to analysts’ expectations of $121.90 million. During the same quarter in the prior year, the company earned $0.27 EPS. As a group, equities analysts anticipate that Orthofix Medical will post -1.27 EPS for the current year.

Institutional Investors Weigh In On Orthofix Medical

Several hedge funds have recently modified their holdings of OFIX. Quantbot Technologies LP purchased a new stake in Orthofix Medical during the first quarter valued at approximately $39,000. CWM LLC lifted its position in Orthofix Medical by 433.4% during the fourth quarter. CWM LLC now owns 1,947 shares of the medical device company’s stock valued at $40,000 after acquiring an additional 1,582 shares during the last quarter. UBS Group AG lifted its position in Orthofix Medical by 2,120.8% during the third quarter. UBS Group AG now owns 2,776 shares of the medical device company’s stock valued at $53,000 after acquiring an additional 2,651 shares during the last quarter. US Bancorp DE purchased a new stake in Orthofix Medical during the third quarter valued at approximately $57,000. Finally, Mutual of America Capital Management LLC lifted its position in Orthofix Medical by 19.0% during the third quarter. Mutual of America Capital Management LLC now owns 3,980 shares of the medical device company’s stock valued at $76,000 after acquiring an additional 636 shares during the last quarter. Hedge funds and other institutional investors own 98.43% of the company’s stock.

About Orthofix Medical

(Get Rating)

Orthofix Medical, Inc engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion.